flupenthixol has been researched along with Weight Gain in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asmal, L; Chiliza, B; du Plessis, S; Emsley, R; Kilian, S; Luckhoff, H; Phahladira, L; Scheffler, F | 1 |
Asmal, L; Chiliza, B; Emsley, R; Erasmus, R; Kidd, M; Malhotra, A; Oosthuizen, P; van Niekerk, E | 1 |
Fielenbach, T; Rave, G; Schindler, R | 1 |
Mogil, JS; Stinus, L; Vaccarino, FJ | 1 |
1 trial(s) available for flupenthixol and Weight Gain
Article | Year |
---|---|
Chronic dopamine antagonism facilitates opiate-induced feeding.
Topics: Animals; Body Weight; Dopamine; Dopamine Antagonists; Drug Synergism; Eating; Flupenthixol; Male; Morphine; Rats; Rats, Wistar; Weight Gain | 1995 |
3 other study(ies) available for flupenthixol and Weight Gain
Article | Year |
---|---|
Weight gain and metabolic change as predictors of symptom improvement in first-episode schizophrenia spectrum disorder patients treated over 12 months.
Topics: Adult; Body Mass Index; Dopamine Antagonists; Female; Flupenthixol; Humans; Longitudinal Studies; Male; Outcome Assessment, Health Care; Schizophrenia; Severity of Illness Index; Weight Gain; Young Adult | 2019 |
Changes in body mass and metabolic profiles in patients with first-episode schizophrenia treated for 12 months with a first-generation antipsychotic.
Topics: Adult; Antipsychotic Agents; Biomarkers; Blood Glucose; Body Mass Index; Cholesterol; Cohort Studies; Female; Flupenthixol; Humans; Male; Metabolic Syndrome; Metabolome; Schizophrenia; South Africa; Triglycerides; Weight Gain | 2015 |
Flupenthixol and cefotiam: effects on vitamin A metabolism in rats.
Topics: Animals; Anti-Bacterial Agents; Carboxylic Ester Hydrolases; Cefotiam; Drug Interactions; Flupenthixol; Kidney; Liver; Male; Rats; Rats, Inbred BN; Rats, Long-Evans; Vitamin A; Weight Gain | 2004 |